Ldspharma

Epicin ® 50 mg Injection

(Epirubicin Hydrochloride 50mg)

GENERIC NAME: Epirubicin Hydrochloride 50mg

THERAPEUTIC CLASS: Antineoplastic Agent- Anthracyclines

INDICATIONS & DOSAGE:

  • Breast Cancer (as an adjuvant therapy)
  • Advanced ovarian cancer
  • Soft tissue sarcoma
  • Non-Hodgkin lymphoma
  • Gastric cancer

STORAGE:Store between 15 °C and 30 °C. Protected from sunlight

PACK SIZE:  1×1’s

DOSAGE & ADMINISTRATION:

The recommended starting dose of Epirubicin is 100 to 120mg/m2 IV infusion for 15-20 minutes repeated 3 to 4 weeks cycle. The total dose of Epirubicin may be given on Day 1 of each cycle or divide equally and given on Days 1 and 8 of each cycle.
Special consideration should be given to administration of lower starting dose of Epirubicin in hepatic dysfunction, bone marrow dysfunction and renal dysfunction patients.